163 related articles for article (PubMed ID: 34091990)
1. Heterogenous expression of endoglin marks advanced renal cancer with distinct tumor microenvironment fitness.
Momoi Y; Nishida J; Miyakuni K; Kuroda M; Kubota SI; Miyazono K; Ehata S
Cancer Sci; 2021 Aug; 112(8):3136-3149. PubMed ID: 34091990
[TBL] [Abstract][Full Text] [Related]
2. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.
Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C
PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180
[TBL] [Abstract][Full Text] [Related]
3. Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells.
Zhong Y; Guan K; Guo S; Zhou C; Wang D; Ma W; Zhang Y; Li C; Zhang S
Cancer Lett; 2010 Dec; 299(2):150-60. PubMed ID: 20846785
[TBL] [Abstract][Full Text] [Related]
4. Endoglin Is Essential for the Maintenance of Self-Renewal and Chemoresistance in Renal Cancer Stem Cells.
Hu J; Guan W; Liu P; Dai J; Tang K; Xiao H; Qian Y; Sharrow AC; Ye Z; Wu L; Xu H
Stem Cell Reports; 2017 Aug; 9(2):464-477. PubMed ID: 28793246
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of the short endoglin isoform reduces renal fibrosis and inflammation after unilateral ureteral obstruction.
Muñoz-Félix JM; Pérez-Roque L; Núñez-Gómez E; Oujo B; Arévalo M; Ruiz-Remolina L; Cuesta C; Langa C; Pérez-Barriocanal F; Bernabeu C; Lopez-Novoa JM
Biochim Biophys Acta; 2016 Sep; 1862(9):1801-14. PubMed ID: 27321931
[TBL] [Abstract][Full Text] [Related]
6. Endoglin (CD105) and SMAD4 regulate spheroid formation and the suppression of the invasive ability of human pancreatic cancer cells.
Kokaji E; Shimomura A; Minamisaka T; Nakajima T; Miwa S; Hatta H; Nishida T; Kiya C; Imura J
Int J Oncol; 2018 Mar; 52(3):892-900. PubMed ID: 29393426
[TBL] [Abstract][Full Text] [Related]
7. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche.
Grange C; Tapparo M; Collino F; Vitillo L; Damasco C; Deregibus MC; Tetta C; Bussolati B; Camussi G
Cancer Res; 2011 Aug; 71(15):5346-56. PubMed ID: 21670082
[TBL] [Abstract][Full Text] [Related]
8. Tumoral CD105 promotes immunosuppression, metastasis, and angiogenesis in renal cell carcinoma.
Oladejo M; Nguyen HM; Seah H; Datta A; Wood LM
Cancer Immunol Immunother; 2023 Jun; 72(6):1633-1646. PubMed ID: 36586013
[TBL] [Abstract][Full Text] [Related]
9. Renal carcinoma CD105-/CD44- cells display stem-like properties in vitro and form aggressive tumors in vivo.
Fiedorowicz M; Khan MI; Strzemecki D; Orzeł J; Wełniak-Kamińska M; Sobiborowicz A; Wieteska M; Rogulski Z; Cheda L; Wargocka-Matuszewska W; Kilian K; Szczylik C; Czarnecka AM
Sci Rep; 2020 Mar; 10(1):5379. PubMed ID: 32214151
[TBL] [Abstract][Full Text] [Related]
10. Functional significance of CD105-positive cells in papillary renal cell carcinoma.
Matak D; Brodaczewska KK; Szczylik C; Koch I; Myszczyszyn A; Lipiec M; Lewicki S; Szymanski L; Zdanowski R; Czarnecka AM
BMC Cancer; 2017 Jan; 17(1):21. PubMed ID: 28056882
[TBL] [Abstract][Full Text] [Related]
11. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
[TBL] [Abstract][Full Text] [Related]
12. Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis.
Paauwe M; Schoonderwoerd MJA; Helderman RFCP; Harryvan TJ; Groenewoud A; van Pelt GW; Bor R; Hemmer DM; Versteeg HH; Snaar-Jagalska BE; Theuer CP; Hardwick JCH; Sier CFM; Ten Dijke P; Hawinkels LJAC
Clin Cancer Res; 2018 Dec; 24(24):6331-6344. PubMed ID: 29945992
[TBL] [Abstract][Full Text] [Related]
13. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
Wang L; Park P; La Marca F; Than KD; Lin CY
J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
[TBL] [Abstract][Full Text] [Related]
14. Reduced tumor growth and angiogenesis in endoglin-haploinsufficient mice.
Düwel A; Eleno N; Jerkic M; Arevalo M; Bolaños JP; Bernabeu C; López-Novoa JM
Tumour Biol; 2007; 28(1):1-8. PubMed ID: 17108712
[TBL] [Abstract][Full Text] [Related]
15. CD105 in the progression and therapy of renal cell carcinoma.
Oladejo M; Nguyen HM; Wood L
Cancer Lett; 2023 Aug; 570():216327. PubMed ID: 37499740
[TBL] [Abstract][Full Text] [Related]
16. Blocking platelet-derived growth factor-D/platelet-derived growth factor receptor beta signaling inhibits human renal cell carcinoma progression in an orthotopic mouse model.
Xu L; Tong R; Cochran DM; Jain RK
Cancer Res; 2005 Jul; 65(13):5711-9. PubMed ID: 15994946
[TBL] [Abstract][Full Text] [Related]
17. Endoglin in human liver disease and murine models of liver fibrosis-A protective factor against liver fibrosis.
Alsamman M; Sterzer V; Meurer SK; Sahin H; Schaeper U; Kuscuoglu D; Strnad P; Weiskirchen R; Trautwein C; Scholten D
Liver Int; 2018 May; 38(5):858-867. PubMed ID: 28941022
[TBL] [Abstract][Full Text] [Related]
18. Endoglin upregulation during experimental renal interstitial fibrosis in mice.
Rodríguez-Peña A; Eleno N; Düwell A; Arévalo M; Pérez-Barriocanal F; Flores O; Docherty N; Bernabeu C; Letarte M; López-Novoa JM
Hypertension; 2002 Nov; 40(5):713-20. PubMed ID: 12411467
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis.
Dubinski W; Gabril M; Iakovlev VV; Scorilas A; Youssef YM; Faragalla H; Kovacs K; Rotondo F; Metias S; Arsanious A; Plotkin A; Girgis AH; Streutker CJ; Yousef GM
Hum Pathol; 2012 Jul; 43(7):1037-43. PubMed ID: 22204709
[TBL] [Abstract][Full Text] [Related]
20. Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity.
Hutton C; Heider F; Blanco-Gomez A; Banyard A; Kononov A; Zhang X; Karim S; Paulus-Hock V; Watt D; Steele N; Kemp S; Hogg EKJ; Kelly J; Jackstadt RF; Lopes F; Menotti M; Chisholm L; Lamarca A; Valle J; Sansom OJ; Springer C; Malliri A; Marais R; Pasca di Magliano M; Zelenay S; Morton JP; Jørgensen C
Cancer Cell; 2021 Sep; 39(9):1227-1244.e20. PubMed ID: 34297917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
